Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma

Alessia Visconti, Niccolò Rossi, Helena Deriš, Karla A. Lee, Maja Hanić, Irena Trbojević-Akmačić, Andrew M. Thomas, Laura A. Bolte, Johannes R. Björk, Jahlisa S. Hooiveld-Noeken, Ruth Board, Mark Harland, Julia Newton-Bishop, Mark Harries, Joseph J. Sacco, Paul Lorigan, Heather M. Shaw, Elisabeth G.E. de Vries, Rudolf S.N. Fehrmann, Rinse K. WeersmaTim D. Spector, Paul Nathan, Geke A.P. Hospers, Peter Sasieni, Veronique Bataille*, Gordan Lauc, Mario Falchi*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)
31 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Keyphrases